MC2290A1 - Benzoquinazolines pharmaceutiquement actives - Google Patents

Benzoquinazolines pharmaceutiquement actives

Info

Publication number
MC2290A1
MC2290A1 MC91@@D MC2290D MC2290A1 MC 2290 A1 MC2290 A1 MC 2290A1 MC 2290 D MC2290 D MC 2290D MC 2290 A1 MC2290 A1 MC 2290A1
Authority
MC
Monaco
Prior art keywords
benzoquinazolines
pharmaceutically active
pharmaceutically
active
active benzoquinazolines
Prior art date
Application number
MC91@@D
Other languages
English (en)
French (fr)
Inventor
William Pendergast
Scott Dickerson
Julius Johnson
Robert Ferone
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC2290A1 publication Critical patent/MC2290A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
MC91@@D 1990-06-19 1991-06-18 Benzoquinazolines pharmaceutiquement actives MC2290A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909013615A GB9013615D0 (en) 1990-06-19 1990-06-19 Pharmaceutical compounds
PCT/GB1991/000977 WO1991019700A1 (en) 1990-06-19 1991-06-18 Pharmaceutically active benzoquinazoline compounds

Publications (1)

Publication Number Publication Date
MC2290A1 true MC2290A1 (fr) 1993-07-14

Family

ID=10677828

Family Applications (1)

Application Number Title Priority Date Filing Date
MC91@@D MC2290A1 (fr) 1990-06-19 1991-06-18 Benzoquinazolines pharmaceutiquement actives

Country Status (26)

Country Link
US (4) US6090941A (xx)
EP (2) EP0535034B1 (xx)
JP (1) JP2966929B2 (xx)
KR (1) KR0183042B1 (xx)
CN (1) CN1049215C (xx)
AP (1) AP218A (xx)
AT (2) ATE260262T1 (xx)
AU (1) AU639815B2 (xx)
CA (1) CA2085589C (xx)
CS (1) CS186391A3 (xx)
DE (2) DE69133371T2 (xx)
DK (2) DK1199307T3 (xx)
ES (2) ES2211851T3 (xx)
FI (1) FI925778A0 (xx)
GB (1) GB9013615D0 (xx)
HU (2) HUT62273A (xx)
IE (1) IE912073A1 (xx)
IL (1) IL98542A (xx)
MC (1) MC2290A1 (xx)
MY (1) MY107001A (xx)
NO (1) NO924929D0 (xx)
NZ (1) NZ238582A (xx)
PL (1) PL169927B1 (xx)
PT (1) PT98021B (xx)
WO (1) WO1991019700A1 (xx)
ZA (1) ZA914676B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
US6420344B1 (en) 1999-03-16 2002-07-16 The Regents Of The University Of California Glycosylated polyamines
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
CA2412165A1 (en) * 2000-06-09 2001-12-20 Claudine S. Ashvar Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
MXPA04002035A (es) * 2001-09-26 2004-06-07 Bayer Pharmaceuticals Corp Derivados de 1, 8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados.
CN100434425C (zh) * 2005-03-09 2008-11-19 首都师范大学 4-喹唑啉酮衍生物及其在抗肿瘤药物中的应用
EP1754484A1 (en) * 2005-08-17 2007-02-21 Dan Stoicescu Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes
EP2206736B1 (en) 2005-12-05 2012-02-08 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
GB0525069D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
JP2010505811A (ja) 2006-10-04 2010-02-25 ファイザー・プロダクツ・インク カルシウム受容体アンタゴニストとしてのピリド[4,3−d]ピリミジン−4(3H)−オン誘導体
EP1958632A1 (en) 2007-02-14 2008-08-20 Dan Stoicescu Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
CN101730549B (zh) * 2007-05-09 2015-12-09 日东电工株式会社 与铂类药物结合的聚合物
JP2010526917A (ja) * 2007-05-09 2010-08-05 日東電工株式会社 複数種の薬物を有するポリグルタミン酸塩複合体及びポリグルタミン酸塩−アミノ酸複合体
EP2155255B1 (en) 2007-05-09 2013-08-14 Nitto Denko Corporation Compositions that include a hydrophobic compound and a polyamino acid conjugate
US8146622B2 (en) 2007-08-20 2012-04-03 Ford Global Technologies, Llc Switch and hose-valve connection arrangement for vehicle temporary mobility kit
US8517760B2 (en) 2007-08-20 2013-08-27 Ford Global Technologies, Llc Cord wrap and power plug receptacle arrangement for inflator
US8501242B2 (en) 2009-05-29 2013-08-06 University Of Florida Research Foundation Methods and compositions for treating neoplasia
CN101580501B (zh) * 2009-06-01 2011-03-09 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体
WO2011078226A1 (ja) * 2009-12-22 2011-06-30 協和発酵キリン株式会社 三環系化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UST862021I4 (en) * 1969-01-27 1969-05-27 Defensive publication
DE2202847A1 (de) * 1971-02-05 1972-08-17 Apaw Sa Speiseeismaschine,insbesondere fuer Familiengebrauch,Kleinbetriebe od.dgl.
EP0031237B1 (en) * 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4603186A (en) 1985-10-21 1986-07-29 The Standard Oil Company Tetrapolymers containing indene
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
US4902624A (en) * 1987-11-23 1990-02-20 Eastman Kodak Company Temperature cycling cuvette
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US5405851A (en) * 1990-06-19 1995-04-11 Burroughs Wellcome Co. Pharmaceutical compounds

Also Published As

Publication number Publication date
IL98542A0 (en) 1992-07-15
ATE222243T1 (de) 2002-08-15
FI925778A (fi) 1992-12-18
CN1058208A (zh) 1992-01-29
DE69133088D1 (de) 2002-09-19
JP2966929B2 (ja) 1999-10-25
US6306865B1 (en) 2001-10-23
AU8094391A (en) 1992-01-07
EP1199307B1 (en) 2004-02-25
DK0535034T3 (da) 2002-12-09
PL169927B1 (pl) 1996-09-30
IE912073A1 (en) 1992-01-01
PT98021B (pt) 1998-11-30
EP1199307A1 (en) 2002-04-24
AP9100283A0 (en) 1991-07-31
ATE260262T1 (de) 2004-03-15
CS186391A3 (en) 1992-04-15
FI925778A0 (fi) 1992-12-18
US5661155A (en) 1997-08-26
US5663337A (en) 1997-09-02
CA2085589A1 (en) 1991-12-20
DE69133371D1 (de) 2004-04-01
NO924929L (no) 1992-12-18
NZ238582A (en) 1993-12-23
EP0535034B1 (en) 2002-08-14
IL98542A (en) 1995-05-26
JPH05507704A (ja) 1993-11-04
ES2178632T3 (es) 2003-01-01
DE69133088T2 (de) 2003-03-20
NO924929D0 (no) 1992-12-18
DK1199307T3 (da) 2004-06-14
US6090941A (en) 2000-07-18
CN1049215C (zh) 2000-02-09
GB9013615D0 (en) 1990-08-08
DE69133371T2 (de) 2005-01-27
PT98021A (pt) 1992-04-30
KR0183042B1 (ko) 1999-05-01
WO1991019700A1 (en) 1991-12-26
ES2211851T3 (es) 2004-07-16
AP218A (en) 1992-09-27
HU211265A9 (en) 1995-11-28
HUT62273A (en) 1993-04-28
MY107001A (en) 1995-08-30
CA2085589C (en) 2001-12-18
KR930701415A (ko) 1993-06-11
HU9204011D0 (en) 1993-03-29
EP0535034A1 (en) 1993-04-07
AU639815B2 (en) 1993-08-05
ZA914676B (en) 1993-02-24

Similar Documents

Publication Publication Date Title
MC2290A1 (fr) Benzoquinazolines pharmaceutiquement actives
FI955941A0 (fi) Farmaseuttisesti aktiivisia CNS-yhdisteitä
TR199501137A2 (tr) Terapötik olarak aktif bilesenler
MX9102473A (es) Agentes farmaceuticos.
NO930543D0 (no) Doseringsform
FI930882A (fi) Farmaceutiska foereningar
FI910254A0 (fi) Oralt aktiva renininhibitorer.
FI931251A (fi) Farmaceutiska foereningar
FI933808A (fi) Insekticidiskt aktiva peptider
IT1229231B (it) Aminoimidazopiridine farmacologicamente attive
DE68908838D1 (de) Pharmazeutisch wirksame Dithioketen-Derivaten.
ITMI921865A1 (it) Glicerofosfoderivati farmacologicamente attivi
DE69130099T2 (de) Antineoplastischer wirkstoff
ITMI910596A1 (it) Gliceroderivati farmacologicamente attivi
IT1229230B (it) Piperidinilimidazopiridine farmacologicamente attive.
DE59206745D1 (de) Aktive Frequenzweiche
SE8902170D0 (sv) Therapeutically active compounds
NO950530D0 (no) Farmasöytisk aktive diketopiperaziner
NO950529D0 (no) Farmasöytisk aktive diketopiperaziner
SE9201338D0 (sv) New active compounds
SE9202553D0 (sv) New active compounds ii
BR9403411A (pt) Cadeira ativa
SE9700660D0 (sv) Pharmaceutically active compounds
SE9303970D0 (sv) New active compounds
SE9203897D0 (sv) New active compounds iii